share_log

Canaccord Genuity Downgrades Vicarious Surgical to Hold, Lowers Price Target to $0.4

Canaccord Genuity Downgrades Vicarious Surgical to Hold, Lowers Price Target to $0.4

Canaccord Genuity 將Vicarious Surgical的評級下調至持有,將目標股價下調至
Benzinga ·  2023/11/14 06:10

Canaccord Genuity analyst Caitlin Cronin downgrades Vicarious Surgical (NYSE:RBOT) from Buy to Hold and lowers the price target from $9 to $0.4.

Canaccord Genuity分析師凱特琳·克羅寧將Vicarious Surgical(紐約證券交易所代碼:RBOT)的評級從買入下調至持有,並將目標股價從9美元下調至0.4美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論